advertisement
11.4 Prostaglandins (17)
Showing records 1 to 17
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins21751 A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost
Simmons ST; Bernstein P; Hollander DA
American Journal of Ophthalmology 2008; 146: 473-477
21662 Topical latanoprost causes posterior movement of lens in a patient with exfoliation syndrome and subluxated lens: A case report
Kanamoto T; Takamatsu M; Kiuchi Y
Journal of Medical Case Reports 2007; 1: 172
21740 Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?
Chang JH; McCluskey P; Missotten T; Ferrante P; Jalaludin B; Lightman S
British Journal of Ophthalmology 2008; 92: 916-921
21873 Intraocular pressure response to medication in a clinical setting: The Marshfield Clinic Personalized Medicine Research Project
McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
Journal of Glaucoma 2008; 17: 372-377
21858 The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: A randomised controlled trial
Ang GS; Kersey JP; Shepstone L; Broadway DC
British Journal of Ophthalmology 2008; 92: 1129-1133
21451 Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure
Cheng J-W; Wei R-L
Clinical Therapeutics 2008; 30: 622-632
21493 Periorbital changes associated with topical bimatoprost
Filippopoulos T; Paula JS; Torun N; Hatton MP; Pasquale LR; Grosskreutz CL
Ophthalmic Plastic and Reconstructive Surgery 2008; 24: 302-307
21556 Safety and efficacy of travoprost adjunctive treatment in paediatric glaucoma
Helmanova I; Autrata R; Senkov K; Rehurek J
Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae 2007; 80: 29-36
21592 Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study
Paolera MD; Kasahara N; Umbelino CC; Walt JG
BMC Ophthalmology 2008; 8: 11
21847 Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
British Journal of Ophthalmology 2008; 92: 1227-1231
21877 Comparison of the effects of latanoprost and bimatoprost on central corneal thickness
Sen E; Nalcacioglu P; Yazici A; Aksakal FN; Altinok A; Tuna T; Koklu G
Journal of Glaucoma 2008; 17: 398-402
21565 Prostaglandin analogues and central corneal thickness
Stefan C; Dumitrica DM; Tebeanu E; Nae I; Sapundgieva A; Dragomir L
Oftalmologia 2007; 51: 95-99
21497 The mechanisms by which latanoprost free acid inhibits human carbonic anhydrase I and II
Sugimoto A; Ikeda H; Tsukamoto H; Kihira K; Takeda C; Hirose J; Hata T; Baba E; Ono Y
Biological & Pharmaceutical Bulletin 2008; 31: 796-801
21504 Tafluprost, a new potent prostanoid receptor agonist: A dose-response study on pharmacodynamics and tolerability in healthy volunteers
Sutton A; Gouws P; Ropo A
International Journal of Clinical Pharmacology and Therapeutics 2008; 46: 400-406
21656 Prostaglandin F2α analogues in glaucoma management
Teus MA; Arranz-Marquez E
Expert Review of Ophthalmology 2008; 3: 203-209
21554 Comparison of daytime efficacy and safety of dorzolamide/timolol maleate fixed combination versus latanoprost
Mulaney J; Sonty S; Ahmad A; Stewart JA; Stewart WC
European Journal of Ophthalmology 2008; 18: 556-562
21488 Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open-angle glaucoma
Rismanchian A; Eslami F; Moeini H; Attarzade H; Naderibeni A
Saudi Medical Journal 2008; 29: 384-387
